Markets Gone Wild

EnWave Corporation Signs Technology Evaluation and License Option Agreement with Solve Solutions Ltda Overview EnWave Corporation has recently announced a Technology Evaluation and License Option Agreement with Solve Solutions Ltda, a prominent Brazilian food company specializing in premium dried fruit, vegetable, and snack products. Solve Solutions targets private label and consumer food brands in Brazil…

Welcome to the Future of AI Investment with VERSES AI Inc. An Exciting Announcement from VERSES AI Inc. On January 7, 2025, VERSES AI Inc. made a significant announcement regarding its securities purchase agreements with AI-focused institutional investors and existing investors of the Company. The Company disclosed that it will be selling 12,738,854 units for…

ZenaTech, Inc. Announces Plans to Acquire Workforce Scheduling Software Company Introduction ZenaTech, Inc. has recently made a significant move in the technology industry by signing a Letter of Intent to acquire a workforce scheduling software company. This strategic decision is aimed at developing quantum computing-driven solutions that will revolutionize the way multinational companies manage their…

United Homes Group, Inc. Operational Unit Statistics Preliminary Operational Unit Statistics for United Homes Group, Inc. COLUMBIA, S.C.–(BUSINESS WIRE)–United Homes Group, Inc. (the “Company”) (NASDAQ: UHG) today announced preliminary operational unit statistics for the quarter and year ended December 31, 2024. Three Months Ended December 31, 2024 Net new orders: 351 (19.4% increase from 2023)…

Cyberon and AIZIP Collaborate with Ceva for Pre-Optimized AI Models Partnerships to Enhance Embedded AI Ecosystem At CES 2025, Ceva, Inc. announced new collaborations with Cyberon Corporation and AIZIP to offer pre-optimized AI models for Ceva-NeuPro-Nano Embedded AI NPUs. These partnerships are aimed at streamlining the development of AI-enabled features such as keyword spotting, face…

Marvel Biosciences Corp. Announces Non-Brokered Private Placement CALGARY, ALBERTA–(Newsfile Corp. – January 7, 2025) Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) (“Marvel” or the “Company”) has revealed plans to carry out a non-brokered private placement of common shares of the Company at a rate of $0.15 per Common Share, with anticipated gross proceeds ranging from…

Welcome to the HCA Healthcare, Inc. 4Q 2024 Earnings Call! Mark Your Calendars for January 24, 2025 Join us for the HCA Healthcare, Inc. 4Q 2024 Earnings Call on Friday, January 24, 2025 at 9:00 AM Central Time (10:00 AM Eastern Time). This is an exciting opportunity to hear firsthand about our company’s performance and…